These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 9164424

  • 1. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients.
    Kiev A, Feiger A.
    J Clin Psychiatry; 1997 Apr; 58(4):146-52. PubMed ID: 9164424
    [Abstract] [Full Text] [Related]

  • 2. Paroxetine versus placebo: a double-blind comparison in depressed patients.
    Claghorn JL, Kiev A, Rickels K, Smith WT, Dunbar GC.
    J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
    [Abstract] [Full Text] [Related]

  • 3. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.
    Ravindran AV, Judge R, Hunter BN, Bray J, Morton NH.
    J Clin Psychiatry; 1997 Mar; 58(3):112-8. PubMed ID: 9108813
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition.
    Ushiroyama T, Ikeda A, Ueki M.
    J Med; 2004 Mar; 35(1-6):151-62. PubMed ID: 18084873
    [Abstract] [Full Text] [Related]

  • 5. Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.
    Weihs KL, Settle EC, Batey SR, Houser TL, Donahue RM, Ascher JA.
    J Clin Psychiatry; 2000 Mar; 61(3):196-202. PubMed ID: 10817105
    [Abstract] [Full Text] [Related]

  • 6. Mirtazapine compared with paroxetine in major depression.
    Benkert O, Szegedi A, Kohnen R.
    J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
    [Abstract] [Full Text] [Related]

  • 7. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
    Claghorn JL, Earl CQ, Walczak DD, Stoner KA, Wong LF, Kanter D, Houser VP.
    J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
    [Abstract] [Full Text] [Related]

  • 8. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.
    Feighner JP, Overø K.
    J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A comparison of paroxetine and placebo in depressed outpatients.
    Dunbar GC, Claghorn JL, Kiev A, Rickels K, Smith WT.
    Acta Psychiatr Scand; 1993 May; 87(5):302-5. PubMed ID: 8517168
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: a double-blind, multicentre study. The LUCIFER Group.
    Haffmans PM, Timmerman L, Hoogduin CA.
    Int Clin Psychopharmacol; 1996 Sep; 11(3):157-64. PubMed ID: 8923094
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.
    Sonawalla SB, Spillmann MK, Kolsky AR, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M.
    J Clin Psychiatry; 1999 Sep; 60(9):580-3. PubMed ID: 10520975
    [Abstract] [Full Text] [Related]

  • 14. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 15. A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder.
    Denys D, van der Wee N, van Megen HJ, Westenberg HG.
    J Clin Psychopharmacol; 2003 Dec; 23(6):568-75. PubMed ID: 14624187
    [Abstract] [Full Text] [Related]

  • 16. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
    McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, Agambaram V, Merideth C, Nordenhem A, Young AH, EMBOLDEN II (Trial D1447C00134) Investigators.
    J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
    [Abstract] [Full Text] [Related]

  • 17. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA, Goldstein BJ, Jacobson AF, Steinbook RM.
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [Abstract] [Full Text] [Related]

  • 18. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
    Baldwin DS, Hawley CJ, Abed RT, Maragakis BP, Cox J, Buckingham SA, Pover GH, Ascher A.
    J Clin Psychiatry; 1996 Mar; 57 Suppl 2():46-52. PubMed ID: 8626363
    [Abstract] [Full Text] [Related]

  • 19. Fluvoxamine for premenstrual dysphoric disorder: a pilot study.
    Freeman EW, Rickels K, Sondheimer SJ.
    J Clin Psychiatry; 1996 Mar; 57 Suppl 8():56-9; discussion 60. PubMed ID: 8698682
    [Abstract] [Full Text] [Related]

  • 20. Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients.
    Fabre L, Birkhimer LJ, Zaborny BA, Wong LF, Kapik BM.
    Int Clin Psychopharmacol; 1996 Jun; 11(2):119-27. PubMed ID: 8803649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.